FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 60 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $460,000 | +191.1% | 23,036 | +0.3% | 0.00% | – |
Q2 2022 | $158,000 | -26.2% | 22,956 | -0.2% | 0.00% | – |
Q1 2022 | $214,000 | -34.6% | 23,004 | +0.1% | 0.00% | – |
Q4 2021 | $327,000 | -38.8% | 22,979 | -0.3% | 0.00% | -100.0% |
Q3 2021 | $534,000 | -21.8% | 23,047 | -16.0% | 0.00% | 0.0% |
Q2 2021 | $683,000 | +3.8% | 27,445 | +16.8% | 0.00% | 0.0% |
Q1 2021 | $658,000 | +8.4% | 23,500 | +35.1% | 0.00% | 0.0% |
Q4 2020 | $607,000 | -16.6% | 17,400 | +19.2% | 0.00% | 0.0% |
Q3 2020 | $728,000 | – | 14,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |